Skip to Content

Diagnocure Inc DGCRF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DGCRF is trading at a 16% discount.
Price
$0.00
Fair Value
$8.75
Uncertainty
Extreme
1-Star Price
$9.79
5-Star Price
$6.87
Economic Moat
Bycthm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DGCRF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$43.04
Volume/Avg
5,000 / 3,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
DGCRF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
DGCRF

Financial Strength

Metric
DGCRF
Quick Ratio
3.45
Current Ratio
3.74
Interest Coverage
2,446.73
Quick Ratio
DGCRF

Profitability

Metric
DGCRF
Return on Assets (Normalized)
156.78%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
184.02%
Return on Assets
DGCRF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRQvxc$550.2 Bil
VRTX
Vertex Pharmaceuticals IncLmqwc$111.1 Bil
REGN
Regeneron Pharmaceuticals IncKdzrn$107.7 Bil
MRNA
Moderna IncBkbn$36.9 Bil
ARGX
argenx SE ADRHyy$24.2 Bil
BNTX
BioNTech SE ADRXnb$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncSmczks$19.9 Bil
BMRN
Biomarin Pharmaceutical IncNxlgk$17.2 Bil
RPRX
Royalty Pharma PLC Class AWvljhr$13.9 Bil
INCY
Incyte CorpGplllp$13.6 Bil

Sponsor Center